Hand-foot syndrome (HFS) as a potential biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU) Meeting Abstract


Authors: Michaelson, M. D.; Cohen, D. P.; Li, S.; Motzer, R. J.; Escudier, B.; Barrios, C. H.; Burnett, P. E.; Puzanov, I.
Abstract Title: Hand-foot syndrome (HFS) as a potential biomarker of efficacy in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (SU)
Meeting Title: 2011 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 7 Suppl.
Meeting Dates: 2011 Feb 17-19
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-03-01
Language: English
ACCESSION: WOS:000208880700319
PROVIDER: wos
DOI: 10.1200/jco.2011.29.7_suppl.320
Notes: Meeting Abstract: 320 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer